Description
| Product Name | Details | CAT.No | Size |
| Microalbumin | Suitable for Hitachi 917 | HIT0471B | R1: 2 x 20ml R2: 1 x 8ml R4: 5 x 1ml |
| Microalbumin | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0471C | R1: 2 x 20ml R2: 1 x 8ml |
| Microalbumin | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF417A | R1: 6 x 20ml R2: 3 x 8ml |
Product Description
The Biorex Diagnostics Microalbumin Assay is a high-quality in vitro diagnostic test designed for the quantitative determination of microalbumin in human urine. Microalbumin is a sensitive biomarker for early renal injury and is widely used in the detection and monitoring of kidney disease, particularly in patients with diabetes and hypertension. Early identification of elevated urinary albumin levels is critical for timely intervention, helping to prevent progression to more severe renal impairment and associated cardiovascular complications.
The use of validated assays provides an objective assessment of laboratory method performance and is an integral part of good laboratory practice. By incorporating the Biorex Microalbumin Assay into routine workflows, laboratories can reliably detect early changes in renal function, monitor disease progression, and support clinical decision-making. The assay’s high sensitivity allows for accurate detection of microalbumin levels within the clinically relevant range (30–300 mg/day), ensuring meaningful and actionable results.
Manufactured under strict quality standards, the Biorex Diagnostics Assay delivers stable and reproducible performance across multiple testing runs. The immunoturbidimetric or colorimetric method ensures high accuracy, reliability, and consistency. The assay is fully compatible with automated analyzers, including Hitachi 917, Olympus AU600/400/640, and CA 180/270/400/2700 Furuno/Daytona systems, enabling seamless integration into laboratory workflows and supporting efficient, high-throughput testing.
Key Features
- Quantitative Measurement: Accurate determination of urinary microalbumin levels.
- Clinical Relevance: Supports early detection of renal dysfunction and diabetic nephropathy.
- High Sensitivity and Reproducibility: Ensures reliable results within clinically relevant ranges.
- Cardiovascular and Renal Risk Assessment: Aids in identifying patients at increased risk.
- Automated Analyzer Compatibility: Optimised for leading clinical chemistry systems.
Benefits
The Biorex Diagnostics Microalbumin Assay provides laboratories with a dependable solution for early detection and monitoring of renal impairment. Its precision, reproducibility, and compatibility with automated systems make it an essential tool for clinical laboratories, hospital diagnostics, and research applications, supporting improved patient outcomes and effective disease management.
Contact Us for more information.